feed,title,long_url,short_url
BioRxiv,Improving the preclinical and clinical success rates of LMW drugs depends on radical revisions to the status quo scientific foundations of medicinal chemistry: a case study on COVID Mpro inhibition,https://biorxiv.org/cgi/content/short/2022.10.31.514572v1?rss=1,https://bit.ly/3DufZPL
